|
Multiple sclerosis
Citations 401-410 of 469 total displayed.
|
Past content
(since Jan 2001):
|
- BRIEF COMMUNICATIONS
Multiple sclerosis–associated retrovirus and MS prognosis: An observational study
- S. Sotgiu, C. Serra, G. Mameli, M. Pugliatti, G. Rosati, G. Arru, and A. Dolei
Neurology 2002; 59: 1071-1073.
[Abstract]
[Full text]
[PDF]
- BRIEF COMMUNICATIONS
Treatment of steroid-unresponsive tumefactive demyelinating disease with plasma exchange
- Yang Mao-Draayer, Steven Braff, William Pendlebury, and Hillel Panitch
Neurology 2002; 59: 1074-1077.
[Abstract]
[Full text]
[PDF]
- VIEWS & REVIEWS
Differential mechanisms of action of interferon-ß and glatiramer acetate in MS
- V. Wee Yong
Neurology 2002; 59: 802-808.
[Abstract]
[Full text]
[PDF]
- ARTICLES
Cardiac adverse effects associated with mitoxantrone (Novantrone) therapy in patients with MS
- R. G. Ghalie, G. Edan, M. Laurent, E. Mauch, S. Eisenman, H. P. Hartung, R. E. Gonsette, M. D. Butine, and D. E. Goodkin
Neurology 2002; 59: 909-913.
[Abstract]
[Full text]
[PDF]
- BRIEF COMMUNICATIONS
Therapy-related acute myeloblastic leukemia after mitoxantrone treatment in a patient with MS
- D. Brassat, C. Recher, E. Waubant, E. Le Page, F. Rigal-Huguet, G. Laurent, G. Edan, and M. Clanet
Neurology 2002; 59: 954-955.
[Abstract]
[Full text]
[PDF]
- ARTICLES
An examination of suicidal intent in patients with multiple sclerosis
- Anthony Feinstein
Neurology 2002; 59: 674-678.
[Abstract]
[Full text]
[PDF]
- ARTICLES
Benefit of interferon ß-1a on MSFC progression in secondary progressive MS
- J. A. Cohen, G. R. Cutter, J. S. Fischer, A. D. Goodman, F. R. Heidenreich, M. F. Kooijmans, A. W. Sandrock, R. A. Rudick, J. H. Simon, N. A. Simonian, E. C. Tsao, and J. N. Whitaker
Neurology 2002; 59: 679-687.
[Abstract]
[Full text]
[PDF]
- ARTICLES
Methylprednisolone effect on brain volume and enhancing lesions in MS before and during IFNß-1b
- A. B. Rao, N. Richert, T. Howard, B.K. Lewis, C.N. Bash, H.F. McFarland, and J. A. Frank
Neurology 2002; 59: 688-694.
[Abstract]
[Full text]
[PDF]
- BRIEF COMMUNICATIONS
Interferon ß1a and depression in secondary progressive MS: Data from the SPECTRIMS Trial
- Scott B. Patten and Luanne M. Metz
Neurology 2002; 59: 744-746.
[Abstract]
[Full text]
[PDF]
- VIEWS & REVIEWS
Proposed diagnostic criteria and nosology of acute transverse myelitis
- Transverse Myelitis Consortium Working Group*
Neurology 2002; 59: 499-505.
[Abstract]
[Full text]
[PDF]
|
|
